Literature DB >> 9926944

p16INK4 mediates contact-inhibition of growth.

R J Wieser1, D Faust, C Dietrich, F Oesch.   

Abstract

Growth of non-transformed cells in vitro is regulated by density-dependent mechanisms via cell-cell contacts, leading to arrest in late G1-phase at confluency (contact-inhibition of growth). In the present study it is shown that this results from p16INK4-mediated dissociation of the complex cdk4-cyclin D1, which is responsible for the inactivation of the gate keeper of G1-S transition, the retinoblastoma protein pRb. As a consequence of the inactivation of cdk4, downstream the activation of cdk2 and hyperphosphorylation and thus inactivation of pRb was impaired. Direct evidence for the central role of p16INK4 in growth control comes from the observation that a competitive inhibitor of p16INK4 repressed contact inhibition of growth. These findings provide an explanation for the high incidence of mutation or loss of INK4 in human tumours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9926944     DOI: 10.1038/sj.onc.1202270

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.

Authors:  X Lin; P Nelson; I H Gelman
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes.

Authors:  Benjamin W Darbro; Galen B Schneider; Aloysius J Klingelhutz
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

3.  Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.

Authors:  Nabeel Bardeesy; Jeffrey Morgan; Manisha Sinha; Sabina Signoretti; Shefali Srivastava; Massimo Loda; Glenn Merlino; Ronald A DePinho
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  The Hippo-YAP signaling pathway and contact inhibition of growth.

Authors:  Barry M Gumbiner; Nam-Gyun Kim
Journal:  J Cell Sci       Date:  2014-02-15       Impact factor: 5.285

5.  Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters.

Authors:  R Palmqvist; J N Rutegârd; B Bozoky; G Landberg; R Stenling
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients.

Authors:  Pooja Malhotra; Rakesh Kochhar; Kim Vaiphei; Jai Dev Wig; Safrun Mahmood
Journal:  World J Gastrointest Oncol       Date:  2010-07-15

7.  p16 gene methylation in colorectal cancers associated with Duke's staging.

Authors:  J Yi; Z W Wang; H Cang; Y Y Chen; R Zhao; B M Yu; X M Tang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 8.  An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer.

Authors:  Marie Robert; Jean-Sébastien Frenel; Emmanuelle Bourbouloux; Dominique Berton Rigaud; Anne Patsouris; Paule Augereau; Carole Gourmelon; Mario Campone
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

9.  Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat.

Authors:  Andrei Seluanov; Christopher Hine; Jorge Azpurua; Marina Feigenson; Michael Bozzella; Zhiyong Mao; Kenneth C Catania; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

10.  Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation.

Authors:  Aneta Swat; Ignacio Dolado; Jose Maria Rojas; Angel R Nebreda
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.